A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 59 (3) , 223-233
- https://doi.org/10.1016/s0376-8716(99)00122-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Plasma concentrations of buprenorphine 24 to 72 hours after dosingPublished by Elsevier ,1999
- Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patientsDrug and Alcohol Dependence, 1997
- Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosingDrug and Alcohol Dependence, 1995
- Alternate-day dosing during buprenorphine treatment of opioid dependenceLife Sciences, 1994
- Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawalClinical Pharmacology & Therapeutics, 1990
- Naloxone reversal of buprenorphine-induced respiratory depressionClinical Pharmacology & Therapeutics, 1989
- Implications of methadone maintenance for theories of narcotic addictionJAMA, 1988
- The Development of an Opiate Withdrawal Scale (OWS)British Journal of Addiction, 1987
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961